跳至主要内容
临床试验/JPRN-jRCTb030190272
JPRN-jRCTb030190272已完成1 期

Clinical study on safety assessment of PRP therapy for iliopsoas impingement after total hip arthroplasty(PRP for illiopsoas impingement) - PRP for iliopsoas impingement

Homma Yasuhiro0 个研究点目标入组 3 人开始时间: 2020年3月31日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
3

研究概览

简要总结

Safety of PRP for psoasimpingement after total hip arthroplasty was demosntrated.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Patients who have symptoms for more than 3 months
  • 2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer
  • 3. More than 20 years old
  • 4. Other , patients who the doctor has determined that it is suitable for this clinicalstudy

排除标准

  • 1. Patients with abnormal platelet counts in peripheral blood
  • 2. Person who smokes a lot(Brinkmanindex>600)
  • 3. Treatment with anticoagulants(Warfarin)
  • 4. Uncontrolled diabetes mellitus :HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration
  • 5. Patients with malignancy
  • 6. Patients less than 6 months after onset of cardiac infarction or cerebral infarction
  • 7. Predictive survival period is less than 1 year
  • 8.Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis)
  • 9.Dialysis patients
  • 10. Compromised host
  • 11. Requiring continued use of oral corticosteroid therapy
  • 12. Less than 20 years old
  • 13. Doctor has determined that it is not suitable for this clinical study

研究者

发起方
Homma Yasuhiro

相似试验